IMMUNIC, INC. — Director's Dealing 2022

Mar 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2022-03-10

Reporting Person: Nash Duane (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-10	Stock Option	$10.88	A	75000	Acquired	2032-03-10	Common Stock (75000)	Direct

Footnotes

F1: The option vests in monthly increments over a period of one year from the grant date.